Article info
PDFEditorial
The importance of treatment protocols for the management of status epilepticus
- Correspondence to Dr Aidan Neligan, NIHR University College London Hospitals Biomedical Research Centre, Department of Clinical & Experimental Epilepsy, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; a.neligan{at}ucl.ac.uk
Citation
The importance of treatment protocols for the management of status epilepticus
Publication history
- First published December 23, 2013.
Online issue publication
April 14, 2016
Article Versions
- Previous version (14 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Status epilepticus: an evidence based guide
- Generalised convulsive status epilepticus: an overview
- Intravenous brivaracetam for the management of refractory focal non-convulsive status epilepticus
- THE MANAGEMENT OF STATUS EPILEPTICUS
- Continuous EEG use and status epilepticus treatment in Australasia: a practice survey of Australian and New Zealand epileptologists
- Continuous midazolam infusion as treatment of status epilepticus
- Management of convulsive status epilepticus in children
- Drug treatment of epilepsy in adults
- Transient bradycardia induced by thiopentone sodium: a unique challenge in the management of refractory status epilepticus
- Multicentre observational status-epilepticus registry: protocol for ICTAL